Devon DiPalma
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Devon DiPalma has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Mari L. Shinohara
Department of Integrative Immunobiology, Duke University School of Medicine
3 shared publications Alejandra V. Contreras
Fox Chase Cancer Center, Blood Cell Development and Function Program, Philadelphia, USA
1 shared publication- Ashutosh K. Mangalam
Immunology Graduate Program, University of Iowa , Iowa City, IA
1 shared publication - David L. Wiest
Fox Chase Cancer Center, Philadelphia, USA
1 shared publication - Elliot Lin
Department of Integrative Immunobiology, Duke University School of Medicine, Durham, NC
1 shared publication - Jeremy J. Ratiu
Department of Immunology, Duke University Medical Center, Durham, USA
1 shared publication
Latest Publications
- Open Access
- 17 June 2025
- Published by Springer Nature in EMBO Molecular Medicine
- Vol. 17 (7) , 1501-1518
Interplay between fungal infections and autoimmunity: mechanisms and therapeutic perspectives
Fungal infections and autoimmunity share a complex, bidirectional relationship that significantly impacts patient outcomes. Emerging evidence highlights how fungal pathogens contribute to autoimmune processes by triggering immune dysregulation. Conversely, autoimmunity and its immunomodulatory treatments increase susceptibility to fungal infections. These interactions manifest through altered immune responses, including changes in inflammatory signaling, antigen recognition, and mycobiome composition. The resulting interplay complicates disease management, necessitating careful balancing of antifungal defenses with immune modulation. This review synthesizes current knowledge on the role of fungal infections in the progression of autoimmune conditions and explores how autoimmune diseases predispose individuals to fungal infections. Key insights emphasize the need for integrative treatment approaches, addressing both infection risks and immune system imbalances.
- 17 June 2025
- Published by Springer Nature in EMBO Molecular Medicine
- Vol. 17 (7) , 1501-1518
Open AccessInterplay between fungal infections and autoimmunity: mechanisms and therapeutic perspectives
Fungal infections and autoimmunity share a complex, bidirectional relationship that significantly impacts patient outcomes. Emerging evidence highlights how fungal pathogens contribute to autoimmune processes by triggering immune dysregulation. Conversely, autoimmunity and its immunomodulatory treatments increase susceptibility to fungal infections. These interactions manifest through altered immune responses, including changes in inflammatory signaling, antigen recognition, and mycobiome composition. The resulting interplay complicates disease management, necessitating careful balancing of antifungal defenses with immune modulation. This review synthesizes current knowledge on the role of fungal infections in the progression of autoimmune conditions and explores how autoimmune diseases predispose individuals to fungal infections. Key insights emphasize the need for integrative treatment approaches, addressing both infection risks and immune system imbalances.
- Open Access
- 6 October 2022
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-18
Loss of Zfp335 triggers cGAS/STING-dependent apoptosis of post-β selection thymocytes
Production of a functional peripheral T cell compartment typically involves massive expansion of the bone marrow progenitors that seed the thymus. There are two main phases of expansion during T cell development, following T lineage commitment of double-negative (DN) 2 cells and after successful rearrangement and selection for functional TCRβ chains in DN3 thymocytes, which promotes the transition of DN4 cells to the DP stage. The signals driving the expansion of DN2 thymocytes are well studied. However, factors regulating the proliferation and survival of DN4 cells remain poorly understood. Here, we uncover an unexpected link between the transcription factor Zfp335 and control of cGAS/STING-dependent cell death in post-β-selection DN4 thymocytes. Zfp335 controls survival by sustaining expression of Ankle2, which suppresses cGAS/STING-dependent cell death. Together, this study identifies Zfp335 as a key transcription factor regulating the survival of proliferating post-β-selection thymocytes and demonstrates a key role for the cGAS/STING pathway in driving apoptosis of developing T cells.
- 6 October 2022
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-18
Open AccessLoss of Zfp335 triggers cGAS/STING-dependent apoptosis of post-β selection thymocytes
Production of a functional peripheral T cell compartment typically involves massive expansion of the bone marrow progenitors that seed the thymus. There are two main phases of expansion during T cell development, following T lineage commitment of double-negative (DN) 2 cells and after successful rearrangement and selection for functional TCRβ chains in DN3 thymocytes, which promotes the transition of DN4 cells to the DP stage. The signals driving the expansion of DN2 thymocytes are well studied. However, factors regulating the proliferation and survival of DN4 cells remain poorly understood. Here, we uncover an unexpected link between the transcription factor Zfp335 and control of cGAS/STING-dependent cell death in post-β-selection DN4 thymocytes. Zfp335 controls survival by sustaining expression of Ankle2, which suppresses cGAS/STING-dependent cell death. Together, this study identifies Zfp335 as a key transcription factor regulating the survival of proliferating post-β-selection thymocytes and demonstrates a key role for the cGAS/STING pathway in driving apoptosis of developing T cells.
- Open Access
- 1 December 2021
- Published by Elsevier in Cell Reports
- Vol. 37 (13) , 110170
Secreted osteopontin from CD4+ T cells limits acute graft-versus-host disease
- 1 December 2021
- Published by Elsevier in Cell Reports
- Vol. 37 (13) , 110170
Open AccessSecreted osteopontin from CD4+ T cells limits acute graft-versus-host disease